LAURA MACIARIELLO: Open Payments
NPI 1730420969 · CLIFTON PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$338 in 13 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $338
Food & beverage: $338
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 2 | $140 |
| ABBVIE INC. | 5 | $93 |
| Abbott Laboratories | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Amgen Inc. | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 2 | $16 |
Products named: AREXVY, UBRELVY, QULIPTA, SHINGRIX, FREESTYLE LIBRE 3, REXULTI, VRAYLAR, XIFAXAN.
Industry payments across NY — which companies pay providers there.
